2.36000 USD
0.17
7.76%
Last update Dec 12, 3:59 PM EST
Market closed
Day range
2.25
2.5
Previous close
2.19000
Open
2.30000
Access this stock data via API
Subscribe
ImmunityBio, Inc.
2.36
0.17
7.76%

Financials

Income statement

Fiscal date 2024 2023 2022 2021
Total reported revenue 14.7M 622K 240K 934K
Cost of revenue 0
Gross profit 14.7M
Operating expense
Research & development 190.1M 232.4M 248.1M 196.0M
Selling general and admin 168.8M 129.6M 102.7M 135.3M
Other operating expenses
Operating income -344.2M -361.4M -350.6M -330.3M
Non operating interest income
Income 2.4M 863K 2.7M 836K
Expense 131.7M 129.2M 63.5M 14.8M
Other income expense 82.5M -94.2M -5.9M -5.5M
Pretax income -413.6M -583.9M -417.3M -349.8M
Tax provision 0 -40K 34K 9K
Net income -413.6M -583.9M -417.3M -349.8M
Basic EPS -0.6 -1.2 -1.0 -0.9
Diluted EPS -0.6 -1.2 -1.0 -0.9
Basic average shares 697.3M 508.6M 399.9M 389.2M
Diluted average shares 697.3M 508.6M 399.9M 389.2M
EBITDA -303.4M -388.0M -342.5M -315.8M
Net income from continuing op. -413.6M -583.9M -417.3M -349.8M
Minority interests 81K 656K 753K 3.1M
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed (non-working day)
Pre-market opens in 13 hours 43 minutes

14:16
00:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).